Because hypoxic responses in cancer cells are primarily mediated by hypoxia inducible factors, targeting HIF-1α directly or indirectly or eradicating intra-tumoral hypoxic regions are viable strategies to inhibit aggressive tumors [8,11,15]. Here, HIF1A is linked to cancer.